Stay updated on Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added related-topic links for Lung cancer and MedlinePlus Genetics to the study page to offer supplementary educational resources.
    Difference
    0.2%
    Check dated 2026-04-02T00:40:13.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Lung cancer and related topics were removed from the page, removing core disease context and related informational links.
    Difference
    0.2%
    Check dated 2026-03-25T21:03:00.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Related topics Lung cancer and MedlinePlus Genetics were added; the site revision was updated to v3.5.0, removing v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-18T17:51:04.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3. The visible study content and links remain unchanged.
    Difference
    0.1%
    Check dated 2026-03-11T16:22:44.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Lung cancer and the MedlinePlus Genetics related topics were removed from the page.
    Difference
    0.2%
    Check dated 2026-03-04T11:45:02.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Added related topics Lung cancer and MedlinePlus Genetics to the related topics section.
    Difference
    0.2%
    Check dated 2026-02-25T08:41:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.